252 related articles for article (PubMed ID: 14871646)
1. T-cell vaccination in multiple sclerosis.
Achiron A; Mandel M
Autoimmun Rev; 2004 Jan; 3(1):25-32. PubMed ID: 14871646
[TBL] [Abstract][Full Text] [Related]
2. T-cell vaccination in multiple sclerosis: update on clinical application and mode of action.
Hellings N; Raus J; Stinissen P
Autoimmun Rev; 2004 Jun; 3(4):267-75. PubMed ID: 15246022
[TBL] [Abstract][Full Text] [Related]
3. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
Stinissen P; Raus J
Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096
[TBL] [Abstract][Full Text] [Related]
4. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
Hermans G; Denzer U; Lohse A; Raus J; Stinissen P
J Autoimmun; 1999 Sep; 13(2):233-46. PubMed ID: 10479392
[TBL] [Abstract][Full Text] [Related]
5. T cell vaccination in experimental autoimmune encephalomyelitis: a mathematical model.
Borghans JA; De Boer RJ; Sercarz E; Kumar V
J Immunol; 1998 Aug; 161(3):1087-93. PubMed ID: 9686566
[TBL] [Abstract][Full Text] [Related]
6. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis].
Rodríguez-Rodríguez Y; Suárez-Luis I
Rev Neurol; 2003 Apr 1-15; 36(7):649-52. PubMed ID: 12666047
[TBL] [Abstract][Full Text] [Related]
7. Protection from autoimmunity by DNA vaccination against T-cell receptor.
Buch T; Waisman A
Methods Mol Med; 2006; 127():269-80. PubMed ID: 16988460
[TBL] [Abstract][Full Text] [Related]
8. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial.
Bar-Or A; Vollmer T; Antel J; Arnold DL; Bodner CA; Campagnolo D; Gianettoni J; Jalili F; Kachuck N; Lapierre Y; Niino M; Oger J; Price M; Rhodes S; Robinson WH; Shi FD; Utz PJ; Valone F; Weiner L; Steinman L; Garren H
Arch Neurol; 2007 Oct; 64(10):1407-15. PubMed ID: 17698695
[TBL] [Abstract][Full Text] [Related]
9. T-cell vaccination in multiple sclerosis: immunoregulatory mechanism and prospects for therapy.
Zhang J
Crit Rev Immunol; 2001; 21(1-3):41-55. PubMed ID: 11642613
[TBL] [Abstract][Full Text] [Related]
10. Autoreactive T cells in multiple sclerosis.
Zhang J; Weiner HL; Hafler DA
Int Rev Immunol; 1992; 9(3):183-201. PubMed ID: 1285060
[No Abstract] [Full Text] [Related]
11. Induction of experimental autoimmune encephalomyelitis in Lewis rats by a viral peptide with limited homology to myelin basic protein.
Mao YS; Lu CZ; Wang X; Xiao BG
Exp Neurol; 2007 Aug; 206(2):231-9. PubMed ID: 17617406
[TBL] [Abstract][Full Text] [Related]
12. T cell vaccination in multiple sclerosis relapsing-remitting nonresponders patients.
Achiron A; Lavie G; Kishner I; Stern Y; Sarova-Pinhas I; Ben-Aharon T; Barak Y; Raz H; Lavie M; Barliya T; Faibel M; Cohen IR; Mandel M
Clin Immunol; 2004 Nov; 113(2):155-60. PubMed ID: 15451472
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis.
De Santi L; Annunziata P; Sessa E; Bramanti P
J Neurol Sci; 2009 Dec; 287(1-2):17-26. PubMed ID: 19758606
[TBL] [Abstract][Full Text] [Related]
14. Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis.
Zang YC; Hong J; Tejada-Simon MV; Li S; Rivera VM; Killian JM; Zhang JZ
Eur J Immunol; 2000 Mar; 30(3):908-13. PubMed ID: 10741408
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides.
Fontoura P; Garren H; Steinman L
Int Rev Immunol; 2005; 24(5-6):415-46. PubMed ID: 16318989
[TBL] [Abstract][Full Text] [Related]
16. Immunopathogenic mechanisms in experimental allergic encephalomyelitis.
Kálmán B; Lublin FD
Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):182-8. PubMed ID: 7683223
[TBL] [Abstract][Full Text] [Related]
17. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.
Stuerzebecher S; Martin R
Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717
[TBL] [Abstract][Full Text] [Related]
18. Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals.
Berthelot L; Laplaud DA; Pettré S; Ballet C; Michel L; Hillion S; Braudeau C; Connan F; Lefrère F; Wiertlewski S; Guillet JG; Brouard S; Choppin J; Soulillou JP
Eur J Immunol; 2008 Jul; 38(7):1889-99. PubMed ID: 18506883
[TBL] [Abstract][Full Text] [Related]
19. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
Holmøy T
Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
[TBL] [Abstract][Full Text] [Related]
20. Epicutaneous (EC) immunization with myelin basic protein (MBP) induces TCRalphabeta+ CD4+ CD8+ double positive suppressor cells that protect from experimental autoimmune encephalomyelitis (EAE).
Tutaj M; Szczepanik M
J Autoimmun; 2007 Jun; 28(4):208-15. PubMed ID: 17442539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
